Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermaprazole for Radiation Dermatitis in Head and Neck Cancer
NCT04865731Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of Dermaprazole in radiation dermatitis, sponsored by UT Health San Antonio. Started Jun 2022; status: completed.
02
Drugs
Dermaprazole
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT04865731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04865731.